Thursday 15 May 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Axsome Therapeutics
A biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Pharmaceutical
Inozyme puts faith in Petra Duda as new CMO
15 May 2025
Pharmaceutical
CNX selected for Inflexion’s record $3 billion fund
15 May 2025
Pharmaceutical
Boehringer and Tempus AI forge multi-year partnership
15 May 2025
More ones to watch news >
Reset all filters
Refine Search
Axsome Therapeutics
Axsome Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Halda Therapeutics
Opthea
OncoZenge
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma


Today's issue

ASCO 2025: Novartis to flex oncology muscles
Pharmaceutical
ASCO 2025: Novartis to flex oncology muscles
15 May 2025
Pharmaceutical
Inozyme puts faith in Petra Duda as new CMO
15 May 2025
Biotechnology
Merck to present broad oncology advances at ASCO 2025
15 May 2025
Biotechnology
Positive new data for Keytruda with Phase III trial in ovarian cancer
15 May 2025
Biotechnology
Gene therapies drive growth of genomics market, says GlobalData
15 May 2025
Pharmaceutical
Saudi firm courts Trump with investment plan
15 May 2025
Biotechnology
FDA Approves AbbVie’s Emrelis
15 May 2025

Company Spotlight

A biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze